⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.
HDFCLIFE - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 3.8
| Stock Code | HDFCLIFE | Market Cap | 1,38,724 Cr. | Current Price | 643 ₹ | High / Low | 821 ₹ |
| Stock P/E | 73.4 | Book Value | 81.4 ₹ | Dividend Yield | 0.33 % | ROCE | 6.53 % |
| ROE | 10.8 % | Face Value | 10.0 ₹ | DMA 50 | 702 ₹ | DMA 200 | 729 ₹ |
| Chg in FII Hold | -0.55 % | Chg in DII Hold | 0.64 % | PAT Qtr | 421 Cr. | PAT Prev Qtr | 447 Cr. |
| RSI | 31.7 | MACD | -23.4 | Volume | 24,63,061 | Avg Vol 1Wk | 31,13,892 |
| Low price | 617 ₹ | High price | 821 ₹ | PEG Ratio | 6.61 | Debt to equity | 0.18 |
| 52w Index | 12.8 % | Qtr Profit Var | 1.40 % | EPS | 8.77 ₹ | Industry PE | 76.2 |
📊 Core Financials
- Quarterly PAT declined slightly from ₹447 Cr. to ₹421 Cr. (~6% sequential drop, ~1.4% YoY growth).
- ROE: 10.8% → moderate profitability.
- ROCE: 6.53% → relatively weak efficiency compared to peers.
- Debt-to-equity: 0.18 → low leverage, financially stable.
- Dividend Yield: 0.33% → minimal cash returns to shareholders.
💹 Valuation Indicators
- P/E Ratio: 73.4 vs Industry PE 76.2 → slightly cheaper than peers but still highly valued.
- P/B Ratio: 7.9 (Current Price ₹643 / Book Value ₹81.4) → expensive relative to assets.
- PEG Ratio: 6.61 → valuation stretched compared to earnings growth.
- Intrinsic Value: Current price above fair value, limited upside potential.
🏢 Business Model & Competitive Advantage
- Leading private life insurance company under HDFC Group.
- Revenue model based on premiums, investment income, and protection products.
- Competitive advantage: Strong brand trust, distribution network, and diversified product portfolio.
📈 Entry Zone & Long-Term Guidance
- Entry Zone: Attractive near ₹617–₹635 (close to 52-week low, RSI at 31.7 indicates oversold).
- Long-Term Holding: Suitable for investors seeking exposure to India’s insurance growth story, but valuations remain expensive.
✅ Positive
- Strong brand under HDFC Group ensures customer trust.
- Low debt-to-equity ratio (0.18) provides financial stability.
- DII holdings increased (+0.64%), showing domestic institutional confidence.
⚠️ Limitation
- High P/E and PEG ratios indicate stretched valuations.
- ROCE and ROE relatively weak compared to peers.
- Dividend yield is very low (0.33%).
📉 Company Negative News
- Quarterly PAT declined from ₹447 Cr. to ₹421 Cr.
- Stock trading below 50 DMA (₹702) and 200 DMA (₹729), indicating bearish momentum.
- MACD at -23.4 signals weak technical trend.
📈 Company Positive News
- Stable long-term growth outlook in insurance sector.
- DII holdings increased (+0.64%), reflecting domestic confidence.
🌐 Industry
- Life insurance industry PE at 76.2, slightly higher than HDFCLIFE’s 73.4.
- Industry growth driven by rising insurance penetration, regulatory support, and increasing demand for protection products.
🔎 Conclusion
- HDFCLIFE is fundamentally stable with strong brand positioning but faces valuation challenges.
- Profitability metrics are moderate, and dividend yield is low.
- Best strategy: Accumulate near ₹617–₹635 and hold long-term to benefit from India’s expanding insurance market, while being cautious of high valuations.